Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | CCR8 | P51685 | 3/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 1/20 | 0.53 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6499571 | 0.83 | ALDH1A1 (0.75) | ALDH1A1CCR8KDM4ETDP1HPGD | |
| SCHEMBL6496864 | 0.81 | ALDH1A1 (0.73) | ALDH1A1CCR8KDM4ETDP1HPGD | |
| SCHEMBL13743319 | 0.80 | ALDH1A1 (0.70) | CYP2D6ALDH1A1TSHRCCR8KCNH2 | |
| SCHEMBL6506121 | 0.79 | CCR8 (0.57) | ALDH1A1CCR8KCNH2KDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL4186299 | 0.79 | ALDH1A1 (0.68) | CYP2D6ALDH1A1TSHRCCR8KCNH2 | |
| SCHEMBL2791333 | 0.79 | FAAH (0.71) | CCR8KCNH2FAAHMGLL | |
| SCHEMBL24798927 | 0.78 | CYP2D6 (0.68) | CYP2D6ALDH1A1CYP3A4TSHRCYP1A2 | |
| SCHEMBL24798656 | 0.78 | CYP2D6 (0.68) | CYP2D6ALDH1A1CYP3A4TSHRCYP1A2 | |
| Hydrochloric Acid SCHEMBL896900 | 0.78 | FAAH (0.58) | CYP2D6ALDH1A1CCR8KCNH2FAAH | |
| SCHEMBL5197063 | 0.78 | CCR8 (0.74) | CYP2D6ALDH1A1CYP3A4CCR8KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143372-A1 | Compounds, pharmaceutical compositions and methods of use therefor | MILLENNIUM PHARMACEUTICALS, INC. | 2005-06-30 | — | — | US | disclosed |
| WO-2003037271-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREFOR | MILLENNIUM PHARMACEUTICALS,INC. (US) | 2003-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143372-A1 | Compounds, pharmaceutical compositions and methods of use therefor | CCR8, CCL11, CCR5 | CYP2D6 1424/4885ALDH1A1 1071/4885CYP3A4 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.